产品资料

重组大鼠BD-1

产品名称: 重组大鼠BD-1
产品型号: PP1001993-250μg
产品展商: PERFEMIKER
产品价格: 0.00 元
会员价格: 0.00 元
产品文档: 无相关文档
我要买:
产品已经成功添加到购物车
你添加了1件产品 查看购物车

简单介绍

名称:重组大鼠BD-1 货号:PP1001993 规格:250μg


重组大鼠BD-1  的详细介绍

名称:重组大鼠BD-1

Synonyms:Defensin beta1

Accession:O89117

GeneID:83687

Source:Escherichia coli.

Molecular Weight:Approximately 4.1 kDa, a single non-glycosylated polypeptide chain containing 37 amino acids.

Quantity:5µg/20µg/1000µg

AA Sequence:DQYRCLQNGG FCLRSSCPSH TKLQGTCKPD KPNCCRS

Purity:> 95 % by SDS-PAGE and HPLC analyses.

Biological Activity:Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using CD34+ dendritic cells is in a concentration range of 100.0-1000.0 ng/ml.

Physical Appearance:Sterile Filtered White lyophilized (freeze-dried) powder.

Formulation:Lyophilized from a 0.2 µm filtered concentrated solution in 20 mM PB, 500 mM NaCl, pH 7.0.

Endotoxin:Less than 1 EU/µg of rRtBD-1 as determined by LAL method.

Reconstitution:We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.

Stability & Storage:Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Reference:1. Wang YS, Wang GQ, Wen YJ, et al. 2007. Clin Cancer Res, 13: 6779-87.
2. Morrison GM, Davidson DJ, Kilanowski FM, et al. 1998. Mamm Genome, 9: 453-7.
3. Kurosawa S, Ohta M, Hayakawa M, et al. 2002. Hybrid Hybridomics, 21: 359-63.
4. Palladino MA, Mallonga TA, Mishra MS. 2003. Biol Reprod, 68: 509-15.
5. Kurland AR, Schreiner H, Diamond G. 2006. J Periodontal Res, 41: 567-72.

Background:Defensins (alpha and beta) are cationic peptides with antimicrobial activity against Gram-negative and Gram-positive bacteria, fungi, and enveloped viruses. They are 2-6 kDa proteins and take important roles in innate immune system. On the basis of their size and pattern of disulfide bonding, mammalian defensins are classified into alpha, beta and theta categories. β-Defensins are expressed on some leukocytes and at epithelial surfaces. They contain a six-cysteine motif that forms three intra-molecular disulfide bonds. Because β-defensins are cationic peptides, they can therefore interact with the membrane of invading microbes, which are negative due to lipopolysaccharides (LPS) and lipoteichoic acid (LTA) found in the cell membrane. Especially, they have higher affinity to the binding site compared to Ca2+ and Mg2+ ions. Furthermore, they can affect the stability of the membrane. Additionally, they are not only have the ability to strengthen the innate immune system but can also enhance the adaptive immune system by chemotaxis of monocytes, T-lymphocytes, dendritic cells and mast cells to the infection site.